Dietary Inflammation Index, developed at Arnold School, could yield important information to reduce cancers

April 12, 2013

Susan Steck

A new study for Dr. Susan Steck will focus on
chronic inflammation and chronic diseases.

Dr. Susan Steck, a researcher in the Department of Epidemiology and Biostatistics at the Arnold School of Public Health, has received a grant from the Prevent Cancer Foundation to study the impact of a dietary inflammatory index on reducing the risks of breast and colorectal cancers.

The two-year award of $80,000 enhances Steck’s research program on the link between chronic inflammation and chronic diseases, including cancers.

“This is particularly apparent for colorectal cancer (CRCA) where use of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, has been found to reduce risk,” said Steck, who also has an appointment within the Cancer Prevention and Control Program at the Arnold School. “Unfortunately, side effects from NSAIDs prohibit their widespread use in preventing cancer. Diet, on the other hand, offers a safer and perhaps even more effective way to reduce inflammation, and consequently, cancer risk.”

Studies have shown that inflammation is an important process in the growth of many types of cancers. Dietary factors have anti- and pro-inflammatory properties, and understanding the factors that inhibit or reduce inflammation could be beneficial in cancer prevention and treatment.

“No nutrient, however, is consumed alone but in conjunction with other nutrients and non-nutrient components of food. We developed and validated a dietary inflammatory index (DII) to assess the overall quality of diet with regard to its inflammation potential,” she said.

Steck and Fred Tabung, an epidemiology graduate student at the Arnold School, recently applied the DII to the Women’s Health Initiative (WHI) Food Frequency Questionnaire (FFQ) data. They found that the DII was significantly associated with three markers of systemic inflammation.

“We inferred from the findings that the FFQ-derived DII is likely to detect significant associations between the inflammatory potential of overall diet and breast and colorectal cancers, two cancers of emphasis in the Prevent Cancer Foundation call for proposals,” said Steck.

“We now propose to utilize data from the WHI observational study and clinical trial to evaluate the impact of this novel DII on postmenopausal breast cancer and colorectal cancer,” she said. “The study will have a large public health impact by strengthening the evidence for a new tool assessing the overall quality of the diet and providing support for its use in other studies of diet and cancer, as well as its future use in intervention studies.”

 

email this page       print this page

Columbia, SC 29208 • 803-777-7000 • sphweb@mailbox.sc.edu